Structural identification ofin vitrometabolites for 23-nordeoxycholic acid by structural analogue matching

23-Nordeoxycholic acid was deployed to probe metabolism pathways of endogenous bile acids, and metabolite identification was achieved by applying the rule that C 23 –CH 2 defect quantitatively modifies both MS 2 spectrum and retention time features.